-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the National Medical Products Administration approved the first class innovative drug Donafinil Tosylate (trade name: Zeprosyn) declared by Suzhou Zejing Biopharmaceutical Co.
, Ltd.
through the priority review and approval procedure
.
The drug is an innovative drug independently researched and developed by China with independent intellectual property rights.
Donafenib (Donafenib) is a multi-kinase inhibitor class of small molecule anti-tumor drugs
.
The listing of this variety provides a new treatment option for patients with hepatocellular carcinoma